The use of mesenchymal stem cells (MSCs) for clinical purposes has skyrocketed in the past
decade. Their multilineage differentiation potentials and immunomodulatory properties have …

Tissue engineering potentially offers new treatments for disorders of the temporomandibular
joint which frequently afflict patients. Damage or disease in this area adversely affects …

Current therapies for multiple sclerosis (MS) are largely palliative, not curative.
Mesenchymal stem cells (MSCs) harbor regenerative and immunosuppressive functions …

In extensive bone defects, tissue damage and hypoxia lead to cell death, resulting in slow
and incomplete healing. Human embryonic stem cells (hESC) can give rise to all specialized …

Protocols based on the delivery of stem cells are currently applied in patients, showing
encouraging results for the treatment of articular cartilage lesions (focal defects …

Mesenchymal stem cells (MSCs) have a high potential for therapeutic efficacy in treating
diverse musculoskeletal injuries and cardiovascular diseases, and for ameliorating the …

Hydrogels are synthetic or natural polymer networks that closely mimic native extracellular
matrices. As hydrogel-based vehicles are being increasingly employed in therapeutic cell …

Abstract Three-dimensional (3D) printed polymer scaffolds can build engineered tissue
constructs with complex and hierarchical structures, mechanical and biological …

Controlled differentiation of human embryonic stem cells (hESCs) and induced pluripotent
stem cells (iPSCs) into cells that resemble adult mesenchymal stem cells (MSCs) is an …

Damage to cartilage represents one of the most challenging tasks of musculoskeletal
therapeutics due to its limited propensity for healing and regenerative capabilities. Lack of …